© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to May
oral prodrug of IDO1 inhibitor
completed Ph. I in solid tumors
from derivatization of indoximod
Eur. J. Med. Chem., May 1, 2020
NewLink Genetics, Ames, IA
NLG802 is a prodrug of the IDO1 inhibitor indoximod with significantly enhanced oral exposure. Both the acid and amine functionalities of indoximod are protected as an ethyl ester and…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.